4th Quarter - Report

CAPITOL HILL STRATEGIES, LLC for MERCK & CO., INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 (Follow on Biologics) H.R. 5629, Pathway for Biosimilars Act (Follow on Biologics) H.R. 1038, Access to Life-Saving Medicine Act (Follow on Biologics)

LobbyistCovered position, as disclosed
CHARLES M BRAIN NA
A. J. WOJCIAK NA

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1956 (110th), H.R. 5629 (110th), H.R. 1038 (110th)

Medical/Disease Research/Clinical Labs MED

H.R. 6381, Medical Device Safety Act of 2008 (Pre-emption legislation to overturn Riegel v. Medtronic)

LobbyistCovered position, as disclosed
CHARLES M BRAIN NA
A. J. WOJCIAK NA

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6381 (110th)

Medicare/Medicaid MMM

H.R. 1424, Emergency Economic Stabilization Act of 2008, (Paul Wellstone Mental Health and Addiction Equity title - Medicaid rebate) H.R. 6983, Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (Medicaid Rebate)

LobbyistCovered position, as disclosed
CHARLES M BRAIN NA
A. J. WOJCIAK NA

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6983 (110th), H.R. 1424 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.